The pontine Kölliker-Fuse nucleus gates facial, hypoglossal, and vagal upper airway related motor activity.
Animals
Facial Nerve
/ drug effects
Female
GABA Agonists
/ pharmacology
Hypoglossal Nerve
/ drug effects
Isonicotinic Acids
/ pharmacology
Kolliker-Fuse Nucleus
/ drug effects
Male
Motor Activity
/ drug effects
Nerve Net
/ drug effects
Phrenic Nerve
/ drug effects
Rats
Rats, Sprague-Dawley
Respiration
/ drug effects
Respiratory Center
Respiratory Rate
/ drug effects
Vagus Nerve
/ drug effects
Airflow
Pneumotaxic center
Postinspiration
Respiratory pattern
Respiratory rhythm
Upper airway
Journal
Respiratory physiology & neurobiology
ISSN: 1878-1519
Titre abrégé: Respir Physiol Neurobiol
Pays: Netherlands
ID NLM: 101140022
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
16
09
2020
revised:
04
10
2020
accepted:
06
10
2020
pubmed:
15
10
2020
medline:
25
11
2021
entrez:
14
10
2020
Statut:
ppublish
Résumé
The pontine Kölliker-Fuse nucleus (KFn) is a core nucleus of respiratory network that mediates the inspiratory-expiratory phase transition and gates eupneic motor discharges in the vagal and hypoglossal nerves. In the present study, we investigated whether the same KFn circuit may also gate motor activities that control the resistance of the nasal airway, which is of particular importance in rodents. To do so, we simultaneously recorded phrenic, facial, vagal and hypoglossal cranial nerve activity in an in situ perfused brainstem preparation before and after bilateral injection of the GABA-receptor agonist isoguvacine (50-70 nl, 10 mM) into the KFn (n = 11). Our results show that bilateral inhibition of the KFn triggers apneusis (prolonged inspiration) and abolished pre-inspiratory discharge of facial, vagal and hypoglossal nerves as well as post-inspiratory discharge in the vagus. We conclude that the KFn plays a critical role for the eupneic regulation of naso-pharyngeal airway patency and the potential functions of the KFn in regulating airway patency and orofacial behavior is discussed.
Identifiants
pubmed: 33053424
pii: S1569-9048(20)30221-4
doi: 10.1016/j.resp.2020.103563
pii:
doi:
Substances chimiques
GABA Agonists
0
Isonicotinic Acids
0
isoguvacine
YTF580771Y
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103563Informations de copyright
Copyright © 2020. Published by Elsevier B.V.